A Radboudumc-led study has demonstrated that chemoradiotherapy can effectively treat rectal cancer, allowing many patients to avoid invasive surgery.
The trial found that the combination of radiation and chemotherapy achieved high cure rates, preserving the rectum in a significant number of participants.
This non-surgical approach represents a major shift in bowel cancer treatment, potentially improving the quality of life for patients by reducing long-term complications.